PTEN, Nine, Eight: A Countdown for Diabetes
CSEF · 2011 Biochemistry/ Molecular Biology Honorable_mention Award
Overview
Objectives/Goals The goal of the project was to evaluate the potential of PTEN/PI3K biochemical pathway in pancreatic beta cell regeneration and improved endogenous insulin production to provide novel options for diabetes treatments of the future. The primary objectives were to determine whether changes in PTEN/PI3K levels affect beta cell mass, and if so, through what mechanism. The central hypothesis was that PTEN removal from beta cells will promote cell growth through sustained progression of cell cycle. Methods/Materials To study the effects of PTEN on beta cell mass in vivo, a knock-out mouse model was selected. Pancreatic tissue samples from PTEN-WT and PTEN-Null mice were obtained, paraffin-embedded, sectioned, formalin-fixed, and histochemically stained. Pictures of tissue sections were obtained using light microscopy and computer-assisted imaging. Areas for islets and pancreas, and their ratios were calculated using the Image J and Microsoft Excel software applications. Two-tailed Student#s t-test was applied to determine the statistical significance of differences between PTEN-WT and PTEN-Null groups. To study the mechanism underlying PTEN-driven change in beta cell mass, a cell line model in vitro was selected. Cyclin D1 expression in mouse PTEN-WT and PTEN-null fibroblast cell lines was compared by SDS-PAGE and Western blot. GAPDH expression was used as an internal control. Results Pancreas of PTEN-Null mice showed greater number of, and larger, islets containing beta cells compared with those in PTEN-WT mice. Quantitative measurements of islet areas confirmed that the increase in beta cell mass in PTEN-Null mice was statistically significant. SDS-PAGE and Western blot analyses of PTEN-WT and PTEN-Null fibroblasts showed increased expression of cyclin D1 in PTEN-Null cells. Conclusions/Discussion The results showed that, as hypothesized, removal of PTEN-mediated negative regulation of biochemical signaling in pancreatic beta cells results in increased beta cell mass. This increase occurs through increased cyclin D1 production.
Summary statement
PTEN may serve as a target for inhibition to increase beta cell mass and endogenous insulin production, reduce dependency on external medications, and provide an effective alternative to treating diabetes.
Help received
Dr. Bangyan Stiles, Assistant Professor, Pharmacology and Pharmaceutical Sciences, USC School of Pharmacy (scientific mentoring); Ni Zeng, Ph.D. candidate, Pharmacology and Pharmaceutical Sciences, USC School of Pharmacy (technical guidance and histochemistry); parents (statistics help).
Awards (1)
- Honorable Mention
Competition history
- CSEF 2011
Resources
Related projects
CSEF · 2013
Investigating the Role of Extracellular Cinacalcet on the Proliferation of MIN6 Pancreatic Beta Cells in vitro
ISEF · 2019
Identifying Key Pathways/Mechanisms for the Generation of Pancreatic Beta Cells by Trans-differentiation of Acinar Cells
ISEF · 2021
Abnormalities of PTPN2 Increases BETA-cell Apoptosis in PP2-Beta Cells Derived from hESCs
ISEF · 2015
The Role of Transcription Factor Pax6 in Maintenance of Pancreatic Beta Cell Identity
CSEF · 2026
Effects of Beta Cell Specific Smc3 Loss on Islet Cell Identity and Inflammation
ISEF · 2014
Enhancing Pancreatic Islet Function in an Obese Mouse Model
ISEF · 2014
INGAP Circles around Diabetes
ISEF · 2026
A Phase One Insulin-Independent Glucose Regulation Cascade Study in Papio anubis Baboons
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects